Published Medical Diagnostic Marker in Cancer This invention provides a reliable diagnostic tool to monitor MMP activity for clinical trials of MMP inhibitors. By Wayne State University
Published Healthcare & Pharmaceuticals Treatment for Multiple Myeloma This technology is a SR-18465 compound, which is an osteoclastogenesis matrix metalloproteinase 13 (MMP-13) highly specific inhibitor for the treatment of multiple myeloma. By Florida Atlantic University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
